How to Validate AI Tools

Why It Matters

Proper AI validation protects regulated industries from compliance breaches and patient‑safety risks while enabling teams to reap efficiency gains. It clarifies responsibility between users and vendors in a rapidly evolving regulatory environment.

Key Takeaways

• AI outputs are nondeterministic, requiring outcome intent focus
• Risk assessment determines validation depth for AI tools
• Low‑risk AI may need only test scenarios, not full cases
• SME review is essential to judge acceptable AI results
• Vendor AI controls impact validation responsibility

Pulse Analysis

Regulators are tightening guidance around artificial intelligence in life‑science quality systems, with the draft Annex 22 offering a first‑step framework. While the draft remains under consultation, it signals that AI‑enabled eQMS modules will soon be subject to the same rigor as traditional software. The core challenge lies in the nondeterministic nature of generative models, which defies the classic "same input, same output" validation paradigm. Quality teams must therefore shift from exact result matching to assessing whether the AI’s output aligns with the intended purpose, a nuance that demands new documentation practices and evidence trails.

A risk‑based validation strategy is the most pragmatic path forward. Teams start by clearly defining the AI tool’s intended use—whether it merely assists, advises, or makes autonomous decisions—and then evaluate potential impacts on patient safety, compliance, and detectability of errors. Low‑risk utilities, such as AI‑driven document search, often satisfy requirements with high‑level test scenarios that confirm functional intent. Conversely, high‑risk decision‑support tools require detailed test cases, explicit acceptance criteria, and rigorous SME evaluation of each output. This layered approach ensures that validation effort matches the tool’s risk profile while preserving regulatory defensibility.

Vendor responsibility cannot be overlooked. AI models are opaque, continuously learning, and prone to drift, so quality teams must interrogate vendors about guardrails, bias mitigation, and ongoing monitoring mechanisms. Incorporating vendor‑provided performance logs and periodic re‑validation into the lifecycle management plan closes the loop between development and operational use. By embedding these practices, organizations not only meet emerging compliance expectations but also build trust in AI’s ability to augment quality processes, reduce manual effort, and maintain consistent, auditable outcomes.